Graduate School of Medical Sciences
A partnership with the Sloan Kettering Institute

Tri-I Outreach Committee (TORC)

Tri-I Outreach Committee (TOrC) focuses on STEM outreach initiatives for K-12 through undergraduate students whose unique experiences are vital to pushing the boundaries of scientific research discovery. These experiences include those who are first generation in college, those with socioeconomic disadvantage, those with chosen experiences that generate a keen orientation to the needs of marginalized individuals and underserved communities, persons with disabilities, persons from under-resourced educational backgrounds, and who have overcome significant hardship in pursuit of higher education. All candidates who believe their lived experiences meet this description are encouraged to apply.

Fungi in the Gut Prime Immunity Against Infection

Illustration of Candida auris

Common fungi, often present in the gut, teach the immune system how to respond to their more dangerous relatives, according to new research from scientists at Weill Cornell Medicine. Breakdowns in this process can leave people susceptible to deadly fungal infections.

The study, published Feb. 5 in Cell, reveals a new twist in the complex relationship between humans and their associated microbes, and points the way toward novel therapies that could help combat a rising tide of drug-resistant pathogens.

Study Identifies ‘Achilles heel’ of Bacteria Linked to Crohn’s Disease

a man posing for a portrait

The discovery of an “Achilles heel” in a type of gut bacteria that causes intestinal inflammation in patients with Crohn’s disease may lead to more targeted therapies for the difficult to treat disease, according to Weill Cornell Medicine and NewYork-Presbyterian investigators.

New Collaborations Awarded Funding from Starr Cancer Consortium

cancer cell illustration

The Starr Cancer Consortium has awarded grant funding to three Weill Cornell Medicine-led multi institution teams to advance their groundbreaking cancer research projects. The grants will support studies on mechanisms that drive lymphoma and urothelial cancers, and the effects of radiation therapy.

Diversity in HIV Genome Presents Challenges for New Test Measuring HIV Reservoir in Patients

a man smiling in a lab with a white coat on

A new test for measuring the reservoir of HIV hidden in the cells of people with HIV failed to detect this reservoir in a significant number of people with a subtype of HIV-1, according to a study from scientists at Weill Cornell Medicine, Simon Fraser University and the British Columbia Centre for Excellence in HIV/AIDS. Modifications to the test, which is frequently used in clinical trials for new HIV-1 treatments and potential cures, could potentially improve its utility.

Annual Awards

annual awards

Student Research

Scientists Discover a Key Genetic Driver of Lymphomas

dna pattern


Mutations in proteins called histone H1, which help package DNA in chromosomes, are a frequent cause of lymphomas, according to a study led by researchers at Weill Cornell Medicine, NewYork-Presbyterian and The Rockefeller University. The findings could lead to new approaches to treating these cancers.

Studies Reveal Clues about Preventing Spaceflight-Related Risks

image of space

Space travel, illnesses like COVID-19, and climbing Mount Everest can trigger the body’s stress response systems in similar ways, according to new studies by Weill Cornell Medicine, space agencies and many other investigators. The discoveries, including new maps of the abundance of mutations and immune changes found in blood cells during spaceflight, may lead to new ways to protect space travelers.

Finding May Lead to New Treatments for Neurofibromatosis

Common symptoms of the genetic disorder neurofibromatosis type 1 (NF1), including skeletal fragility and the loss of bone mass, may be treatable with an existing anti-cancer drug, according to a study from researchers at Weill Cornell Medicine. The findings reveal the potential for an expanding array of therapeutic options for patients who have this difficult-to-treat condition.